GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential
Open accessThe DOI matches its Crossref record; 286 of the 286 references it cites were found in a registry or an index.
Abstract
G protein-coupled estrogen receptor (GPER) significantly influences metabolic regulation by engaging multiple signaling pathways that affect overall metabolic health. Its structure and signaling mechanisms drive its diverse roles. Our team and others have successfully demonstrated that GPER modulates nutrient metabolism, spanning glucose, protein, and lipid metabolism, while also contributing to vitamin and mineral metabolism. Studies have linked GPER to metabolic disorders, including type 2 diabetes, nonalcoholic fatty liver disease, metabolic syndrome, and cardiovascular diseases, as well as thyroid disorders, highlighting its wide-reaching metabolic impact. GPER holds promise for energy balance and weight management by regulating energy expenditure and thermogenesis. Moreover, it appears to influence the metabolism of cancer cells during tumor progression. Rapid advancements in GPER agonist and antagonist research have highlighted the therapeutic potential of GPER agonists for treating metabolic diseases. Further investigations into GPER biology, mechanisms, and clinical applications will support novel therapeutic strategies, establishing GPER as a key target in metabolic research and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many of the beneficial effects of E2 on energy metabolism are increasingly being attributed to its interaction with GPER1, including its rapid effects on insulin sensitivity, hepatic glucose and lipid metabolism (132, 133).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [133]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The metabolic benefits of E2 have been well studied, with evidence that it promotes insulin-sensitivity and improved lipid metabolism in tandem with estrogen receptors, primarily ERα (90) and GPER1 (133).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [133]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Yang, H., Wang, C., Liao, H., & Wang, Q. (2021) · Oncology Letters · doi:10.3892/ol.2021.12693 · Cited by 31
RetractedRepertoires of Autophagy in the Pathogenesis of Ocular Diseases
Li, Y.-J., Jiang, Q., Cao, G.-F., Yao, J., & Yan, B. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373980 · Cited by 16,304
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227 · cited 1×
“It also induces autophagy to support cell survival, regulating enzymes such as ACC and HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) to limit adipocyte processes [64, 65].”
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
AMPK: guardian of metabolism and mitochondrial homeostasis
Herzig, S., & Shaw, R. J. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2017.95 · Cited by 4,061
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
Hardie, D. G. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2249 · Cited by 2,216 · cited 1×
“AMPK inhibits fatty acid synthesis via acetyl-CoA carboxylase (ACC) phosphorylation and promotes glucose uptake by facilitating glucose transport protein 4 (GLUT4) translocation [62, 63], increasing insulin secretion [64].”
The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030
Vogel, B., Acevedo, M., Appelman, Y., Bairey Merz, C. N., Chieffo, A., Figtree, G. A., Guerrero, M., Kunadian, V., Lam, C. S. P., Maas, A. H. E. M., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00684-x · Cited by 1,488
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
Thomas, P., Pang, Y., Filardo, E. J., & Dong, J. (2005) · Endocrinology · doi:10.1210/en.2004-1064 · Cited by 1,407 · cited 1×
“Upon ligand binding, GPER activates Gαs, stimulating adenylyl cyclase (AC) to increase intracellular cAMP levels [27].”
Nrf2 and Oxidative Stress: A General Overview of Mechanisms and Implications in Human Disease
Ngo, V., & Duennwald, M. L. (2022) · Antioxidants · doi:10.3390/antiox11122345 · Cited by 1,130 · cited 1×
“The activation of GPER has been reported to stimulate the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway [121, 122], resulting in the upregulation of the expression of antioxidant enzymes, including superoxide dismutase (SOD) and glutathione peroxidase (GPx) [123].”
The G-protein-coupled estrogen receptor GPER in health and disease
Prossnitz, E. R., & Barton, M. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2011.122 · Cited by 925 · cited 1×
“This activation also improves metabolic health, reduces adiposity, and increases insulin sensitivity [85].”
Research works printed but not linked: 3
- Sirizi MAG, Esmailidehaj M, Mohamadi-Zarch SM, et al. Cardioprotective effects of Gper agonist in ovariectomized diabetic rats: reversing Er stress and structural changes. Naunyn Schmiedebergs Arch Pharmacol. 2025;398(3):2855–65. https://doi.org/10.1007/s00210-024-03438-4. · DOI
- Pepermans RA, Sharma G, Prossnitz ER. G protein-coupled estrogen receptor in cancer and stromal cells: functions and novel therapeutic perspectives. Cells. 2021. https://doi.org/10.3390/cells10030672. · DOI
- Gupta A, Shinde PG, Jorvekar S, et al. G protein-coupled oestrogen receptor regulates branched-chain amino acid metabolism through c-jun n-terminal kinase. FEBS Lett. 2025. https://doi.org/10.1002/1873-3468.70030. · DOI
Cited by
Lee, A. A., & Den Hartigh, L. J. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1682231 · Cited by 32
Hao, X., Cao, H., Shi, B., Bai, C., Liu, X., & Meng, X. (2026) · iScience · doi:10.1016/j.isci.2026.114890 · Cited by 6
“55 The potential endocrine disrupting effects of BPB and BPAF elevate the risk of ovarian disease, uterine lesions, and breast cancer.”
Targeting GLP1 receptor for reducing global cardiovascular risk
Curcio, A., Meringolo, F., Marincolo, C., Polimeni, A., & Costanzo, S. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-07736-8 · Cited by 1
“It has been demonstrated that G-protein coupled estrogen receptors increase resistance to oxidative damage [52] and exert anti-inflammatory effects by inhibiting the mitogen activated protein kinase (MAPK) pathways [53] reducing cardiac arrhythmias [54].”
Ormiston, K., Shinde, N., Sarathy, G., Zhang, A., Bauer, M., Shukla, R. K., Alsammerai, S., Gupta, A., Bennouna, D., Wesolowski, J., et al. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27041951 · Cited by 2
“Activation of GPER by estrogen has shown to regulate tissue metabolism specifically by increasing oxidative phosphorylation, promoting aerobic glycolysis, and reducing adipocyte hypertrophy [23–25].”
Self-citationMore than alternative estrogen receptors: the emerging role of GPER-1 and ERα36 in breast cancer
Molina, L., Torres, R. F., Spies, J., Meneses, S. S., Soto, M., Carrasco, J., Gálvez, J., Muñoz, D., Soto, J., & Arancibia, Y. (2026) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2026.1002377 · Cited by 1
Metadata
- Authors
- Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., Li, J., Zeng, X., Hu, Q., Huang, X., Xu, X., Dong, H., Zhong, J., Huang, Y., Lv, Q., Liu, B., Qiu, Y.-A., & Yu, T.
- Affiliations
- Jiangxi Provincial Cancer Hospital (CN)
- Jiangxi University of Traditional Chinese Medicine (CN)
- Nanchang University (CN)
- Nanchang Medical College (CN)
- University of Chicago Medical Center (US)
- The University of Agriculture, Peshawar (PK)
- Corresponding author
- Liu, Bo
- Yu, Tenghua
- ORCID
- Venue
- Journal of Translational Medicine
- Published
- 2025-08-26
- Volume
- 23
- Issue
- 1
- Pages
- 960-960
- ISSN
- 1479-5876 (ISSN-L)
- PMC
- PMC12382220
- OpenAlex
- W4413658314
- Cited by
- 13
- References
- 284
- Citations by year
- 2026: 12 · 2025: 1
- FWCI
- 1.99
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc-nd
- creativecommons.org/licenses/by-nc-nd/4.0 (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0 (vor)
- Locations
- Journal of Translational Medicine (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (82160565, 82260565)
- Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province (20232BCJ23035)
- Education Department of Jiangxi Province (GJJ2203532)
- General Project of Jiangxi Provincial Administration of Traditional Chinese Medicine (2023B1281)
- Open Research Fund of Jiangxi Cancer Hospital & Institute (2021J16)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- G protein-coupled estrogen receptor, metabolic homeostasis, nutrient metabolism, glucose metabolism, lipid metabolism, protein metabolism, type 2 diabetes, non-alcoholic fatty liver disease, metabolic syndrome, cardiovascular disease, thyroid dysfunction, energy balance, thermogenesis, cancer metabolism, metabolic disease treatment
- MeSH terms
- Animals, Energy Metabolism, Homeostasis, Humans, Metabolic Diseases, Receptors, Estrogen, Signal Transduction, Receptors, G-Protein-Coupled
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential. https://app.cochat.ai/papers/10.1186/s12967-025-07005-0
- The paper
- Liu, L., Zhou, Y., Liu, J., Zhang, X., He, C., Zeng, X., Dejenie, R., Zeb, U., Zeng, Q., Liu, L., Li, J., Zeng, X., Hu, Q., Huang, X., Xu, X., Dong, H., Zhong, J., Huang, Y., Lv, Q., . . . Yu, T. (2025). GPER in metabolic homeostasis and disease: molecular mechanisms, nutritional regulation, and therapeutic potential. Journal of Translational Medicine. https://doi.org/10.1186/s12967-025-07005-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.